This is consistent with in vitro and in vivo studies showing a deregulation of the G1/S transition after downregulation of Per2 in murine breast cancer cells [51], and cyclin D1-dependent cell cycle deregulation in Per2-/- mice models [52]. This evidence concerns the gene CCND1 and breast carcinoma.